Surgical robot manufacturers face new US FDA premarket guidance

The United States Food and Drug Administration has issued draft guidance setting out recommendations for premarket submissions for robotically assisted surgical devices. It covers non-clinical testing, clinical data and labelling, with the aim of creating a more consistent review framework for devices that combine robotic technology with surgical instruments. Comments are invited until 24 November 2026.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.